Europe digital surgery technologies market was valued at $79.9 million in 2021 and will grow by 30.8% annually over 2021-2030, driven by burgeoning complexities in clinical decision-making and an increase in surgeon's workload, increasing R&D investments, and technological advancements in AI, IoT, big data, extended reality (ER), and digitalization. Highlighted with 35 tables and 60 figures, this 118-page report “Europe Digital Surgery Technologies Market 2021-2030 by Offering, Produc...
Asia Pacific digital surgery technologies market will grow by 35.8% annually with a total addressable market cap of $2,168.9 million over 2021-2030, driven by burgeoning complexities in clinical decision-making and an increase in surgeon's workload, increasing R&D investments, and technological advancements in AI, IoT, big data, extended reality (ER), and digitalization. Highlighted with 32 tables and 59 figures, this 118-page report “Asia Pacific Digital Surgery Technologies Market 2...
Global clinical diagnostics market will reach $ 135,531.4 million by 2031, growing by 7.4% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressur...
North America clinical diagnostics market is projected to grow by 6.6 % annually in the forecast period and reach $53,670.4 million by 2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular dis...
Europe clinical diagnostics market was valued at $16,808.4 million in 2021 and will grow by 7.0% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood p...
Asia Pacific clinical diagnostics market will grow by 9.8% annually with a total addressable market cap of $257.46 billion over 2022-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular disea...
Global CRISPR gene editing market will reach $16,329.8 million by 2031, growing by 26.4% annually over 2021-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic. Highlighted with 87 tables and 86 figures, this 180-page report “...
North America CRISPR Gene Editing market is projected to grow by 24.4% annually in the forecast period and reach $5,976.7 million by 2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic. Highlighted with 28 tables and 50 figures,...
Europe CRISPR Gene Editing market was valued at $397.7 million in 2021 and will grow by 27.3% annually over 2021-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic. Highlighted with 38 tables and 54 figures, this 125-page repor...
Asia Pacific CRISPR Gene Editing market will grow by 28.6% annually with a total addressable market cap of $21.45 billion over 2022-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic. Highlighted with 35 tables and 53 figures,...
